Journal of Risk

BV–VPIN: Measuring the impact of order flow toxicity and liquidity on international equity markets

Rand Low, Te Li and Terry Marsh

  • BV-VPIN effectively predicts high levels of volatility in the equities indices of several countries when applied on daily equities data.
  • If used as a flight-to-quality indicator for an active strategy to time investments bonds vs equities, it effectively outperforms a buy-and-hold strategy.
  • We find support for the application of BV-VPIN in international equities markets as a risk monitoring and management tool for portfolio managers and regulators.

Order flow toxicity is the measure of a trader’s exposure to the risk that counterparties possess private information or other informational advantages. High levels of order flow toxicity can culminate in market makers providing liquidity at a loss or in the suboptimal execution of trades. From a regulatory perspective, high levels of toxicity can be harmful to overall market liquidity and precede precipitous drops in asset prices. The bulk volume–volume-synchronized probability of informed trading (BVVPIN) model is one way of measuring the “toxicity” component of order flow, and it has been successfully applied in high-frequency trading environments. We apply the BVVPIN to daily data from a range of international indexes in order to extend previous analyses of its properties. We find that a rise in BVVPIN effectively foreshadows high levels of volatility in the equity indexes of several countries. If a BVVPIN futures contract were to exist, we show that it would exhibit safe haven characteristics during market downturns. In particular, a simple active portfolio management strategy that times investments in equities (risk-free assets) when BVVPIN levels are low (high) outperforms a buy-and-hold strategy. Thus, we find support for the application of BVVPIN in international equity markets as a risk monitoring and management tool for portfolio managers and regulators.

To continue reading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: